Carl-Stephan Leonhardt

849 total citations
27 papers, 493 citations indexed

About

Carl-Stephan Leonhardt is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Carl-Stephan Leonhardt has authored 27 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Surgery and 9 papers in Epidemiology. Recurrent topics in Carl-Stephan Leonhardt's work include Pancreatic and Hepatic Oncology Research (21 papers), Neuroendocrine Tumor Research Advances (7 papers) and Pancreatitis Pathology and Treatment (7 papers). Carl-Stephan Leonhardt is often cited by papers focused on Pancreatic and Hepatic Oncology Research (21 papers), Neuroendocrine Tumor Research Advances (7 papers) and Pancreatitis Pathology and Treatment (7 papers). Carl-Stephan Leonhardt collaborates with scholars based in Austria, Germany and United States. Carl-Stephan Leonhardt's co-authors include Oliver Strobel, Ulla Klaiber, Thilo Hackert, Thomas Hank, Christine Tjaden, John P. Neoptolemos, Markus W. Büchler, Karen H. Vousden, Georgi N. Yordanov and Michael P. Murphy and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Carl-Stephan Leonhardt

22 papers receiving 491 citations

Peers

Countries citing papers authored by Carl-Stephan Leonhardt

Since Specialization

Citations

This map shows the geographic impact of Carl-Stephan Leonhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl-Stephan Leonhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl-Stephan Leonhardt more than expected).

Fields of papers citing papers by Carl-Stephan Leonhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl-Stephan Leonhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl-Stephan Leonhardt. The network helps show where Carl-Stephan Leonhardt may publish in the future.

Co-authorship network of co-authors of Carl-Stephan Leonhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Carl-Stephan Leonhardt. A scholar is included among the top collaborators of Carl-Stephan Leonhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl-Stephan Leonhardt. Carl-Stephan Leonhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Management of complications occurring after pancreatic surgery 2026 ·European surgery. Supplement/European surgery ·Ulla Klaiber, (unknown), (unknown), Carl-Stephan Leonhardt, (unknown)	0
2	Neoadjuvant Treatment is a Risk Factor for Clinically Relevant Chyle Leak (ISGPS Grade B/C) After Pancreatic Cancer Resection: A Retrospective Cohort Study 2025 ·Annals of Surgical Oncology ·Carl-Stephan Leonhardt, (unknown), (unknown), Ulf Hinz, Georgios Polychronidis, Thomas Hank, Martin Schneider, Thilo Hackert, Oliver Strobel, Martin Loos, Markus W. Buechler, Mohammed Al‐Saeedi	0
3	A systematic review and meta-analysis of morbidity and pancreatic fistula after distal pancreatectomy with versus without prophylactic intra-abdominal drainage 2024 ·International Journal of Surgery ·Ulla Klaiber, Peter Collins, (unknown), (unknown), Martin Schindl, Klaus Sahora, Carl-Stephan Leonhardt, Oliver Strobel	4
4	Evidence-based cancer care: assessing guideline adherence of multidisciplinary tumor board recommendations for breast and colorectal cancer in a non-academic medical center 2024 ·Journal of Cancer Research and Clinical Oncology ·Carl-Stephan Leonhardt, (unknown), (unknown), Ulla Klaiber, I Häuser, Oliver Strobel, Gerald W. Prager, Martin Bodingbauer	0
5	Abstract B079: Identification of synergistic drug combinations including MEK inhibitor and agents modulating the tumor microenvironment in an electroporation-induced pancreatic cancer model 2024 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Carl-Stephan Leonhardt, Oliver Strobel, Oliver Politz, Dieter Zopf, Daniel Baumann, (unknown), Rienk Offringa	0
6	Intraoperative strategies and techniques to achieve surgical radicality in pancreatic cancer 2024 ·European surgery. Supplement/European surgery ·Thomas Hank, Carl-Stephan Leonhardt, Ulla Klaiber, Oliver Strobel	2
7	The revised R status is an independent predictor of postresection survival in pancreatic cancer after neoadjuvant treatment 2024 ·HPB ·Carl-Stephan Leonhardt, Dietmar Pils, Motaz Qadan, Keith D. Lillemoe, Klaus Sahora, Cristina R. Ferrone, Ulla Klaiber, Andrew L. Warshaw, Oliver Strobel, Carlos Fernández‐del Castillo, Thomas Hank	0
8	Prognostic Factors for Early Recurrence After Resection of Pancreatic Cancer: A Systematic Review and Meta-Analysis 2024 ·Gastroenterology ·Carl-Stephan Leonhardt, (unknown), Ulla Klaiber, (unknown), (unknown), (unknown), (unknown), Oliver Strobel	9
9	Patient reported outcomes of duodenum-preserving pancreatic head resection in chronic pancreatitis: high effectivity is impaired by prolonged non-surgical management 2023 ·HPB ·Carl-Stephan Leonhardt, Willem Niesen, Dietmar Pils, (unknown), Thomas Hank, Jörg Kaiser, C. von Schéele, Ulf Hinz, Thilo Hackert, Markus W. Büchler, Oliver Strobel	1
10	Prognostic impact of resection margin status on survival after neoadjuvant treatment for pancreatic cancer: systematic review and meta-analysis 2023 ·International Journal of Surgery ·Carl-Stephan Leonhardt, Thomas Hank, Dietmar Pils, (unknown), Klaus Sahora, Martin Schindl, Caroline S. Verbeke, Oliver Strobel, Ulla Klaiber	9
11	The Revised R Status Is an Independent Predictor of Postresection Survival in Pancreatic Cancer after Neoadjuvant Treatment 2023 ·HPB ·Carl-Stephan Leonhardt, Dietmar Pils, Gerd Jomrich, Klaus Sahora, Andrew L. Warshaw, Cristina R. Ferrone, Monika Schindl, Keith D. Lillemoe, Oliver Strobel, Carlos Fernández‐del Castillo, Thomas Hank	1
12	Defining oligometastatic pancreatic cancer: a systematic review and critical synthesis of consensus 2023 ·ESMO Open ·Carl-Stephan Leonhardt, Tanja Stamm, Thomas Hank, Gerald W. Prager, Oliver Strobel	9
13	Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinoma 2022 ·European Journal of Surgical Oncology ·Carl-Stephan Leonhardt, Ulf Hinz, Jörg Kaiser, Thomas Hank, Christine Tjaden, Frank Bergmann, Thilo Hackert, Markus W. Büchler, Oliver Strobel	3
14	Prognostic relevance of the revised R status definition in pancreatic cancer: meta-analysis 2022 ·BJS Open ·Carl-Stephan Leonhardt, Willem Niesen, Eva Kalkum, Rosa Klotz, Thomas Hank, Markus W. Büchler, Oliver Strobel, Pascal Probst	21
15	Resected Early-Onset Pancreatic Cancer: Practices and Outcomes in an International Dual-Center Study 2022 ·Annals of Surgical Oncology ·Carl-Stephan Leonhardt, Benedict Kinny‐Köster, Thomas Hank, Joseph R. Habib, Sami Shoucair, Ulla Klaiber, John L. Cameron, Thilo Hackert, Christopher L. Wolfgang, Markus W. Büchler, Jin He, Oliver Strobel	7
16	Single-cell analysis of patient-derived PDAC organoids reveals cell state heterogeneity and a conserved developmental hierarchy 2021 ·Nature Communications ·Teresa G. Krieger, Solange Le Blanc, Julia Jabs, Foo Wei Ten, Naveed Ishaque, Katharina Jechow, Olivia Debnath, Carl-Stephan Leonhardt, Anamika Giri, Roland Eils, Oliver Strobel, Christian Conrad	75
17	IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy 2021 ·European Journal of Surgical Oncology ·Jörg Kaiser, (unknown), Ulf Hinz, Carl-Stephan Leonhardt, Thomas Hank, (unknown), Christine Tjaden, Thilo Hackert, Frank Bergmann, Markus W. Büchler, Oliver Strobel	20
18	Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer 2019 ·Cancer Discovery ·Timothy J. Humpton, (unknown), Gina M. DeNicola, Dan Lü, Georgi N. Yordanov, Carl-Stephan Leonhardt, Melissa A. Yao, Priya Alagesan, (unknown), Youngkyu Park, Jeremy N. Skepper, Kay F. Macleod, Pedro A. Pérez–Mancera, Michael P. Murphy, Gérard I. Evan, Karen H. Vousden, David A. Tuveson	139
19	Neoadjuvant and adjuvant chemotherapy in pancreatic cancer 2018 ·Langenbeck s Archives of Surgery ·Ulla Klaiber, Carl-Stephan Leonhardt, Oliver Strobel, Christine Tjaden, Thilo Hackert, John P. Neoptolemos	58
20	Identification of the RNA recognition element of the RBPMS family of RNA-binding proteins and their transcriptome-wide mRNA targets 2014 ·RNA ·Thalia A. Farazi, Carl-Stephan Leonhardt, Neelanjan Mukherjee, Aleksandra Mihailović, Song Li, Klaas E.A. Max, Cindy Meyer, Masashi Yamaji, Pavol Čekan, (unknown), Stefanie Gerstberger, (unknown), Erik Larsson, Uwe Ohler, Thomas Tuschl	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact